| For: | Shida D, Kitayama J, Yamaguchi H, Yamashita H, Mori K, Watanabe T, Nagawa H. Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells. World J Gastroenterol 2005; 11(36): 5638-5643 [PMID: 16237757 DOI: 10.3748/wjg.v11.i36.5638] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i36/5638.htm |
| Number | Citing Articles |
| 1 |
Donghong He, Viswanathan Natarajan, Randi Stern, Irina A. Gorshkova, Julian Solway, Ernst Wm. Spannhake, Yutong Zhao. Lysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E2 release via C/EBPβ in human bronchial epithelial cells. Biochemical Journal 2008; 412(1) doi: 10.1042/BJ20071649
|
| 2 |
Subramaniam Ramachandran, Dai Shida, Masayuki Nagahashi, Xianjun Fang, Sheldon Milstien, Kazuaki Takabe, Sarah Spiegel. Lysophosphatidic acid stimulates gastric cancer cell proliferation via ERK1‐dependent upregulation of sphingosine kinase 1 transcription. FEBS Letters 2010; 584(18) doi: 10.1016/j.febslet.2010.08.035
|
| 3 |
Vassilis Aidinis, Christiana Magkrioti. Autotaxin and lysophosphatidic acid signalling in lung pathophysiology. World Journal of Respirology 2013; 3(3): 77-103 doi: 10.5320/wjr.v3.i3.77
|
| 4 |
Yutong Zhao, Donghong He, Randi Stern, Peter V. Usatyuk, Ernst Wm. Spannhake, Ravi Salgia, Viswanathan Natarajan. Lysophosphatidic acid modulates c-Met redistribution and hepatocyte growth factor/c-Met signaling in human bronchial epithelial cells through PKC δ and E-cadherin. Cellular Signalling 2007; 19(11) doi: 10.1016/j.cellsig.2007.07.005
|
| 5 |
Regina A. Oyesanya, Zendra P. Lee, Jinhua Wu, Jing Chen, Yuanda Song, Abir Mukherjee, Paul Dent, Tomasz Kordula, Huiping Zhou, Xianjun Fang. Transcriptional and post‐transcriptional mechanisms for lysophosphatidic acid‐induced cyclooxygenase‐2 expression in ovarian cancer cells. The FASEB Journal 2008; 22(8) doi: 10.1096/fj.07-101428
|
| 6 |
Makoto Tsuiji, Tsutomu Tsuji, Atsushi Kodaka, Yuki Yoshida, Satoru Inoue, Dai Shida. Sphingosine kinase 1 is upregulated with lysophosphatidic acid receptor 2 in human colorectal cancer. World Journal of Gastroenterology 2016; 22(8): 2503-2511 doi: 10.3748/wjg.v22.i8.2503
|
| 7 |
Satish Kalari, Yutong Zhao, Ernst Wm. Spannhake, Evgeny V. Berdyshev, Viswanathan Natarajan. Role of acylglycerol kinase in LPA-induced IL-8 secretion and transactivation of epidermal growth factor-receptor in human bronchial epithelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology 2009; 296(3) doi: 10.1152/ajplung.90431.2008
|
| 8 |
HONGTAO WANG, FEI KE, JIE ZHENG. Hedgehog-glioma-associated oncogene homolog-1 signaling in colon cancer cells and its role in the celecoxib-mediated anti-cancer effect. Oncology Letters 2014; 8(5) doi: 10.3892/ol.2014.2439
|
| 9 |
Karen M. Kassel, Nancy A. Schulte, Stacey M. Parker, Aaron D. Lanik, Myron L. Toews. Lysophosphatidic Acid Decreases Epidermal Growth Factor Receptor Binding in Airway Epithelial Cells. The Journal of Pharmacology and Experimental Therapeutics 2007; 323(1) doi: 10.1124/jpet.107.120584
|
| 10 |
Christine E. Horak, Jong Heun Lee, Abdel G. Elkahloun, Mathieu Boissan, Sylvie Dumont, Tara K. Maga, Sandrine Arnaud-Dabernat, Diane Palmieri, William G. Stetler-Stevenson, Marie-Lise Lacombe, Paul S. Meltzer, Patricia S. Steeg. Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2
. Cancer Research 2007; 67(15) doi: 10.1158/0008-5472.CAN-07-0962
|
| 11 |
Yutong Zhao, Viswanathan Natarajan. Lysophosphatidic acid signaling in airway epithelium: Role in airway inflammation and remodeling. Cellular Signalling 2009; 21(3) doi: 10.1016/j.cellsig.2008.10.010
|
| 12 |
Kang Jin Jeong, Soon Young Park, Ji Hye Seo, Kyung Bok Lee, Wahn Soo Choi, Jeung Whan Han, Jae Ku Kang, Chang Gyo Park, Yong Kee Kim, Hoi Young Lee. Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells. Experimental and Molecular Medicine 2008; 40(6) doi: 10.3858/emm.2008.40.6.607
|
| 13 |
Christine E. Horak, Arnulfo Mendoza, Eleazar Vega-Valle, Mary Albaugh, Cari Graff-Cherry, William G. McDermott, Emily Hua, Maria J. Merino, Seth M. Steinberg, Chand Khanna, Patricia S. Steeg. Nm23-H1 Suppresses Metastasis by Inhibiting Expression of the Lysophosphatidic Acid Receptor EDG2
. Cancer Research 2007; 67(24) doi: 10.1158/0008-5472.CAN-07-3175
|
| 14 |
Kazushige Kawai, Joji Kitayama, Nelson H. Tsuno, Eiji Sunami, Toshiaki Watanabe. Thrombocytosis before pre-operative chemoradiotherapy predicts poor response and shorter local recurrence-free survival in rectal cancer. International Journal of Colorectal Disease 2013; 28(4) doi: 10.1007/s00384-012-1594-4
|
| 15 |
William H. Fiske, David Threadgill, Robert J. Coffey. ERBBs in the gastrointestinal tract: Recent progress and new perspectives. Experimental Cell Research 2009; 315(4) doi: 10.1016/j.yexcr.2008.10.043
|
| 16 |
C. Chris Yun, Ajay Kumar. Diverse roles of LPA signaling in the intestinal epithelium. Experimental Cell Research 2015; 333(2) doi: 10.1016/j.yexcr.2014.11.013
|
| 17 |
Mariati Abdul Rahman, May Leng Tan, Steven P. Johnson, Robert J. Hollows, Wen Lin Chai, Jason P. Mansell, Lee Fah Yap, Ian C. Paterson. Deregulation of lysophosphatidic acid metabolism in oral cancer promotes cell migration via the up-regulation of COX-2. PeerJ 2020; 8 doi: 10.7717/peerj.10328
|
| 18 |
Dai Shida, Xianjun Fang, Tomasz Kordula, Kazuaki Takabe, Sandrine Lépine, Sergio E. Alvarez, Sheldon Milstien, Sarah Spiegel. Cross-talk between LPA1 and Epidermal Growth Factor Receptors Mediates Up-regulation of Sphingosine Kinase 1 to Promote Gastric Cancer Cell Motility and Invasion. Cancer Research 2008; 68(16) doi: 10.1158/0008-5472.CAN-08-0411
|
| 19 |
Tamotsu Tanaka, Mayumi Ohmoto, Katsuya Morito, Hiroki Kondo, Mai Urikura, Kiyoshi Satouchi, Akira Tokumura. Type 2 lysophosphatidic acid receptor in gastric surface mucous cells: Possible implication of prostaglandin E2production. BioFactors 2014; 40(3) doi: 10.1002/biof.1147
|
| 20 |
Jong Heun Lee, Jean-Claude Marshall, Patricia S. Steeg, Christine E. Horak. Altered gene and protein expression by Nm23-H1 in metastasis suppression. Molecular and Cellular Biochemistry 2009; 329(1-2) doi: 10.1007/s11010-009-0124-3
|
| 21 |
I. V. Epifantseva, T. A. Vinogradova, I. I. Marakhova. Ouabain-dependent activation of protein kinase ERK1/2 and the transcription factor STAT3 in carcinoma A431 cells. Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology 2007; 1(2) doi: 10.1134/S1990747807020055
|
| 22 |
Patricia S. Steeg, Christine E. Horak, Kathy D. Miller. Clinical-Translational Approaches to the Nm23-H1 Metastasis Suppressor. Clinical Cancer Research 2008; 14(16) doi: 10.1158/1078-0432.CCR-08-0238
|
| 23 |
Monica Aasrum, Vegard Tjomsland, G. Hege Thoresen, Paula M. De Angelis, Thoralf Christoffersen, Ingvild J. Brusevold. PI3K is required for both basal and LPA‐induced DNA synthesis in oral carcinoma cells. Journal of Oral Pathology & Medicine 2016; 45(6) doi: 10.1111/jop.12384
|